ROP
Roper Technologies, Inc.
ROP's fundamentals are strong: it turned 31% of its revenue into free cash flow and revenue grew 9.2%. Its PE of 19x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect earnings growth.
ROP Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Stable |
ROP's profitability and cash flow are currently strong, and its revenue and balance sheet are stable.
ROP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $423 | -11% |
| Current | 19x | $478 | — |
| Forward | 20x | $478 | — |
| Fair | 28x | $720 | +51% |
| Expensive | 42x | $1,073 | +124% |
Historical ranges are pointers, not guarantees.
ROP's PE is in its cheap range at 19x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 20x.
ROP Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for ROP, with profitability improving.
ROP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.21 | -4.5% |
| Q3 2026 | $25.34 | +75% |
| Q2 2026 | $24.14 | +70% |
| Q1 2026 | $16.01 | +16% |
| Q4 2025 | $14.20 | -1% |
| Q3 2025 | $14.51 | +6.1% |
| Q2 2025 | $14.23 | +5.4% |
| Q1 2025 | $13.86 | +0.6% |
| Q4 2024 | $14.34 | +11% |
ROP's earnings per share have fallen from their peak: $25.34 over the past year, against $42.58 in late 2022. Its recent earnings include one-off gains.
ROP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +7.6% |
| Q2 2026 | $2.1B | +8.5% |
| Q1 2026 | $2.1B | +11% |
| Q4 2025 | $2.1B | +9.7% |
| Q3 2025 | $2B | +14% |
| Q2 2025 | $1.9B | +13% |
| Q1 2025 | $1.9B | +12% |
| Q4 2024 | $1.9B | +16% |
ROP's revenue has grown year over year for 14 quarters in a row: $2.2B last quarter, up 7.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 29% | +0.3 points |
| Q2 2026 | 28% | -0.5 points |
| Q1 2026 | 27% | -0.8 points |
| Q4 2025 | 29% | +0.6 points |
| Q3 2025 | 28% | +0.3 points |
| Q2 2025 | 28% | -0.6 points |
| Q1 2025 | 28% | -0.7 points |
| Q4 2024 | 28% | -0.7 points |
ROP's operating margin was 29% last quarter, about level with the same quarter a year ago.
ROP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $820.6M | -5.6% |
| Q2 2026 | $469.5M | +16% |
| Q1 2026 | $592.1M | +12% |
| Q4 2025 | $738M | +2.2% |
| Q3 2025 | $869.5M | +15% |
| Q2 2025 | $404.1M | +5.2% |
| Q1 2025 | $528.7M | -0.5% |
| Q4 2024 | $722.2M | +16% |
ROP generated $2.6B in free cash flow over the past year, up 3.8% from the year before.
ROP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -1.2M shares |
| 1 year | -8.3% | -9M shares |
| 3 years | -7.6% | -8.2M shares |
| 5 years | -6.8% | -7.3M shares |
| Available history | -5.4% | -5.7M shares |
ROP has 99M diluted shares, down 8.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $1.2B |
| Q1 2026 | $1.5B |
ROP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.9x | Moderate |
| Q2 2026 | 3.4x | Elevated |
| Q1 2026 | 3.2x | Elevated |
| Q4 2025 | 2.9x | Moderate |
| Q3 2025 | 3.0x | Moderate |
| Q2 2025 | 2.9x | Moderate |
| Q1 2025 | 2.5x | Moderate |
| Q4 2024 | 2.7x | Moderate |
ROP's net debt is about 2.9 years of its operating earnings (EBITDA), about the same as a year ago.
ROP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.3 | Overbought |
| Stochastic | 86.5 | Overbought |
ROP's weekly RSI is 70 (overbought) and its Stochastic is 87 (overbought).
ROP PE vs Industrials Sector
| Metric | ROP | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 24x | 22% below |
| PE % | 28 | 58 | 30 pts below |
ROP is trading at 19x earnings, a 22% discount to the Industrials sector's median of 24x, though its recent earnings include one-off gains.
ROP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $414.9 | 15% above |
| 20 week MA | $398.5 | 20% above |
| 50 week MA | $380.7 | 26% above |
| 100 week MA | $458.4 | 4.2% above |
| 200 week MA | $484.8 | 1.4% below |
ROP has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 1.4% below its 200-week average.
ROP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $357.3 | $420.1 | +18% |
| 2021 | $420.1 | $478.3 | +14% |
| 2022 | $478.3 | $430.1 | -10% |
| 2023 | $430.1 | $545.2 | +27% |
| 2024 | $545.2 | $523.9 | -3.9% |
| 2025 | $523.9 | $450.8 | -14% |
| 2026 YTD | $450.8 | $477.9 | +6% |
ROP has finished lower in three of the last six years. It's up 6% so far in 2026.